REG - MyCelx Tech. Corp. MyCelx Tech. Corp.. - Director/PDMR Shareholding <Origin Href="QuoteRef">MYXR.L</Origin>

Mycelx TechnologiesAnnouncement

15/07/2015 18:54

RNS Number : 9589N
MyCelx Technologies Corporation
21 May 2015
MyCelx Technologies Corporation 
("MyCelx" or the "Company") (AIM: MYX)
21 May 2015
Grant of Share Option to Director
The Company announces that it has been notified on 20 May 2015 by Mark Clark, Chief Financial Officer and a director of the Company, that he was granted an option on 20 May 2015 under the MyCelx Omnibus Performance Incentive Plan ("Plan") over the Company's common shares of US$0.025 each ("Common Shares"). The grant to Mr. Clark was as follows:
Name of Director
Number of share options granted
Exercise price
Total number of share options held following this notification
Total number of share options as % of current issued share capital





Mark Clark 
20,000
US$2.15 *
81,667
0.44%
In addition, following this transaction, Mr. Clark continues to be interested in 47,553 Common Shares, representing 0.26 per cent of the present issued capital of the Company.
Grant of Share Option to Chief Business Development Officer
The Company further announces that it has been notified on 20 May 2015 by Connie Mixon, Chief Executive Officer and a director of the Company, that her husband Mark Mixon, Chief Business Development Officer, was granted an option on 20 May 2015 under the Plan over 76,000 Common Shares. The grant to Mr. Mixon was as follows:
Name 
Number of share options granted
Exercise price
Total number of share options held following this notification
Total number of share options as % of current issued share capital





Mark Mixon 
76,000
US$2.15 *
200,204
1.07%
In addition, following this transaction, Mr. Mixon continues to be interested in 10,000 Common Shares, representing 0.05 per cent of the present issued capital of the Company, which he holds as custodian for his son.
Following this transaction, Ms. Mixon is interested in an aggregate (including the interests of Mr. Mixon) of 991,210 Common Shares, representing 5.32 per cent of the present issued capital of the Company, and in options over an aggregate (including the interests of Mr. Mixon) of 363,221 Common Shares, representing 1.95 per cent of the present issued capital of the Company. 
The aggregate number of Common Shares held by Ms. Mixon also includes (a) 150,000 shares held by limited liability companies controlled by Ms. Mixon; and (b) 202,646 shares held by or on behalf of Ms. Mixon's children.
The above grants formed part of wider grants of 319,000 options to a total of fifteen employees across the Company, on the same date, representing 1.71% of the current issued share capital. 
The share options granted on 20 May 2015 will vest as to one third on each of the first, second and third anniversaries of the date of grant, and must be exercised prior to the tenth anniversary of the date of grant, subject to the restrictions on dealing under the Company's share dealing code. 
*Based on the mid-market closing price of the Company's Common Shares at 19 May 2015, and the closing US/ exchange rate at that date.
For further information please contact:
MyCelx Technologies Corporation
Connie Mixon, CEO
Mark Clark, CFO
Tel: +1 888 306 6843
Numis Securities Limited 
Corporate Finance 
John Prior
Paul Gillam
Corporate Broking
James Black
Ben Stoop 
Tel: +44 20 7260 1000
Bell Pottinger
Nick Lambert
Henry Lerwill
Tel: +44 20 3772 2500

This information is provided by RNS
The company news service from the London Stock Exchange
  END
RDSLLFEVETILFIE